Plasma Lipid Metabolites Differentiate Metabolic From Viral Chronic Liver Disease
Lipid metabolites demonstrated pathways common to, and unique to, HIV, HCV, and MASLD. Further studies will hopefully reveal the pathogenic role of these metabolites in liver disease severity, particularly in PWH with steatotic liver disease.
Authors
- Kara Wegermann (ORCID: https://orcid.org/0000-0002-1024-9040)
- Joseph E. Lucas
- Keyur Patel (ORCID: https://orcid.org/0000-0002-4677-3127)
- Laura G. Dubois (ORCID: https://orcid.org/0009-0007-9668-1216)
- Susanna Naggie (ORCID: https://orcid.org/0000-0001-7721-6975)
- Li Zhong (ORCID: https://orcid.org/0000-0001-8142-5702)
- Cynthia A. Moylan (ORCID: https://orcid.org/0000-0001-8454-7086)
- Rebecca Mangus
Institutions
- University Health Network (CA)
- Duke University (US)
- Abterra Biosciences (United States) (US)
- Vital Research (US)
- Durham VA Medical Center (US)
- Duke University Health System (US)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1093/infdis/jiaf270
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35